|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/4704 | (2006.01) |
| A61P 25/00 | (2006.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/18 | (2006.01) | ||
| A61P 25/22 | (2006.01) | ||
| A61P 25/24 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 31/138 | (2006.01) | ||
| A61K 31/428 | (2006.01) |
| (11) | Number of the document | 2467372 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10808442.7 |
| Date of filing the European patent application | 2010-08-09 | |
| (97) | Date of publication of the European application | 2012-06-27 |
| (45) | Date of publication and mention of the grant of the patent | 2016-05-18 |
| (46) | Date of publication of the claims translation | 2016-08-25 |
| (86) | Number | PCT/US2010/002194 |
| Date | 2010-08-09 |
| (87) | Number | WO 2011/019375 |
| Date | 2011-02-17 |
| (30) | Number | Date | Country code |
| 273920 P | 2009-08-10 | US |
| (72) |
HAYARDENY, Liat, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd.,
5 Basel Street P.O. Box 3190, 49131 Petah Tiqva,
IL
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Su BDNF susijusių sutrikimų gydymas, naudojant lakvinimodą |
| TREATMENT OF BDNF-RELATED DISORDERS USING LAQUINIMOD |
| Payment date | Validity (years) | Amount | |
| 2018-07-19 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-08-09 |